Protection of the cardiovascular system

Protection of the cardiovascular system

1-MNA influences blood vessel tension thereby reducing the risk of cardiovascular diseases, including atherosclerosis, arterial hypertension and chronic heart failure.

Protection of the cardiovascular system
Proper activity of the vascular endothelium
Proper activity of the vascular endothelium

Proper activity of the vascular endothelium

By increasing nitric oxide (NO) bioavailability, 1-MNA is directly related to the proper function of the endothelium. Impaired endothelial activity results in the development of many diseases such as cardiac diseases, vascular system diseases, gastrointestinal diseases, hepatic diseases and diabetes.

Anti-inflammatory activity

Anti-inflammatory activity

1-MNA through its effects on the secretory function of the vascular endothelium, contributes to lowering the level of proinflammatory cytokines and inflammatory markers, such as hsCRP and TNF-α. Proper levels of these markers contribute to the reduced the risk of diseases caused by inflammation.

Anti-inflammatory activity
Anticoagulant activity
Anticoagulant activity

Anticoagulant activity

1-MNA stimulates the secretion of endogenous prostacyclin (PGI2), which reduces platelet aggregation, thereby reducing the creation of blood clots in arteries.

Anti-atherosclerotic activity

Anti-atherosclerotic activity

Studies have demonstrated that 1-MNA reduces the amount of atherosclerotic plaque and reduces the level of cholesterol in blood, which together reduce the risk of atherosclerosis.

Anti-atherosclerotic activity